- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Undervalued based on future growth
Global Pharmaceuticals & Biotech Undervalued based on future growth
Results
40
2 new
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
40 companies
Decibel Cannabis
Market Cap: CA$75.0m
An integrated cannabis company, engages in the cannabis cultivation in Canada.
DB
CA$0.13
7D
0%
1Y
100.0%
Earth Science Tech
Market Cap: US$41.6m
Together with its subsidies, focuses on health and wellness industry.
ETST
US$0.14
7D
-11.2%
1Y
18.5%
Labiana Health
Market Cap: €30.8m
Develops, manufactures, sells, and markets animal and human health medicine products in Spain, rest of European Union, and internationally.
LAB
€4.40
7D
0%
1Y
105.6%
Oncodesign Precision Medicine Société anonyme
Market Cap: €8.5m
A biopharmaceutical company, engages in the precision medicine business.
ALOPM
€0.47
7D
-6.7%
1Y
-54.4%